Kristi Funk, M.D., FACS, medical director and co founder of the Pink Lotus Breast Center, describes why there is a lack of awareness surrounding the link between breast cancer and nutrition.
In this interview, Kristi Funk, M.D., FACS, explained that because nutrition isn’t discussed in depth in medical schools, many physicians do not talk about it with patients. This leads to 72% of patients lacking this information, according to a recent survey published by the Physicians Committee for Responsible Medicine, a non-profit research and advocacy organization based in Washington, D.C. The Physicians Committee for Responsible Research is a group dedicated to promoting animal rights and overall wellness through plant-based diets and ethical research. Their 15-minute, online survey was conducted in July of this year and included 2,017 women from the United States.
Funk is a board-certified breast cancer surgeon based in Santa Monica, California as well as a member of the President's Counsel of the Physicians Committee for Responsible Medicine. She is also the author of the national bestseller "Breasts: The Owner's Manual."
How Financial Toxicity Screening Can Be Incorporated Into Everyday Healthcare in America
November 15th 2024Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can also happen in generalized healthcare, according to Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
Differences in Defining 'Clinically Meaningful' in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More